Skip to content

Clinical Efficacy of the Polycon Hysteroscopic Tissue Resection System (HTRS) versus Hysteroscopic Electroresection for the Treatment of Endometrial Polyps: A Single-Blind, Randomized Controlled Trial

Clinical Efficacy of the Polycon Hysteroscopic Tissue Resection System (HTRS) versus Hysteroscopic Electroresection for the Treatment of Endometrial Polyps: A Single-Blind, Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088319
Enrollment
Unknown
Registered
2024-08-15
Start date
2024-08-15
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial polyp

Interventions

experimental group:Use of the PolyGone single-use hysteroscopic tissue rotator and biopsy device during hysteroscopic surgery
control group:Bipolar electrocoagulation system is used in hysteroscopic surgery

Sponsors

Women's Hospital School of Medicine Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1)Aged between 20 and 40 years old; 2)Clinical manifestations include abnormal uterine bleeding (AUB-p), large polyps, or infertility or miscarriage considered to be related to polyps, with indications for endometrial polyp resection surgery; 3)Confirmed to have endometrial polyps through B-ultrasound, hysteroscopy examination, and postoperative pathology; 4)Voluntarily participating in this clinical trial and having signed an informed consent form in writing.

Exclusion criteria

Exclusion criteria: 1)Patients with suspected cancerous changes or precancerous lesions combined with endometrial cancer. 2)Patients with acute or chronic infectious diseases, severe abnormalities in liver and kidney function, and coagulation mechanism disorders. 3)Patients with severe physical or mental illnesses, whom the researcher considers may affect treatment, assessment, or have poor compliance with the research protocol. 4)Patients who cannot tolerate surgery. 5)Patients with cervical scars that prevent dilation of the cervix. 6)Patients with uterine malformations such as uterine septum or didelphys uterus. 7)Patients with breast cancer. 8)Patients in a state of pregnancy.

Design outcomes

Primary

MeasureTime frame
Postoperative recurrence of endometrial polyps;

Secondary

MeasureTime frame
pregnancy outcome;Operative index;operative complication;Postoperative recovery;

Countries

China

Contacts

Public ContactWang Yue

Women's Hospital School of Medicine Zhejiang University

misswangyue@zju.edu.cn+86 137 7786 2608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026